ContraFect Company
ContraFect is developing first-in-class biologic therapies for life-threatening, drug-resistant infectious diseases.
Technology:
Others
Industry:
Altered Signaling
Headquarters:
United States
Founded Date:
2008
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership